• Home
The News Universe
No Result
View All Result
No Result
View All Result
The News Universe
No Result
View All Result

Pegasus Angel Accelerator Opens Applications for Accelerate: $100K Investment for Founders Ready to Go from Grit to Scale

admin by admin
September 4, 2025
in Uncategorized
0
Pegasus Angel Accelerator Opens Applications for Accelerate: $100K Investment for Founders Ready to Go from Grit to Scale
Pegasus Accelerate
Pegasus Angel Accelerator has opened applications for Accelerate, its flagship accelerator offering $100K investments and tailored support for founders ready to scale.

SANTA MONICA – September 4, 2025 – Pegasus Angel Accelerator today announced that applications are officially open for Accelerate, its flagship accelerator designed for founders who are past the idea stage and poised to scale.

Unlike traditional accelerators, Accelerate focuses exclusively on startups already in motion — teams that are shipping, selling, and iterating with real customers. Selected companies receive a $100K investment along with access to a battle-tested tactical advisory network of operators, growth leaders, and investors.

“Accelerate is not a program. It’s a partnership,” said the Pegasus team. “We back founders who have already proven grit — people who’ve built something real and are now ready to scale it.”

Who It’s For

  • Founders with traction, not just a deck

  • Teams already shipping, selling, and learning

  • Operators with a bias toward execution, not excuses

Accelerate provides more than capital. Founders tap into Pegasus’ curated ecosystem to:

  • Sharpen growth foundations and scalable processes

  • Strengthen investor readiness and storytelling

  • Connect with aligned capital partners through strategic warm introductions

Pegasus rejects the traditional Demo Day model. Instead, founders are matched with investors through curated Lightning Rounds, targeted 1:1 sessions, and warm intros tailored to stage and fit.

“Accelerate is built for outliers — the founders who keep building when others hesitate.”

How It Works

Every founder’s journey looks different. That’s why Pegasus builds a hyper-personalized curriculum for each Accelerate company — mapping tactical advisory, operator support, and investor introductions directly to the founder’s most pressing needs. Instead of one-size-fits-all workshops, founders get custom playbooks designed to accelerate their specific growth bottlenecks.

Founders selected for Accelerate also become part of Pegasus’ broader ecosystem of builders, mentors, and investors. The relationship doesn’t end after funding: alumni continue to access resources, introductions, and perks designed to reduce burn and extend runway.

Applications are now open, and Pegasus is looking to write a few more checks before summer ends.

Apply Here

About Pegasus Angel Accelerator

Pegasus is the #1 investment and growth acceleration firm in Southern California dedicated to identifying and scaling high-potential brands and startups. Led by Lucas Pols, Pegasus combines deep industry expertise with strategic capital to transform innovative businesses into market leaders. With headquarters in Los Angeles and global footprint, our team of seasoned entrepreneurs, operators, and investors brings decades of collective experience in building and scaling successful companies. Learn more at pegasusangelaccelertor.com. Follow us on LinkedIn.

Media Contact
Company Name: VentureVoice Media
Contact Person: Mila Hart
Email: Send Email
Country: United States
Website: venturevoicemedia.com

Previous Post

Type 1 Diabetes Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Eli Lilly and Company, Regor Pharma, AstraZeneca, Eccogene, Pfizer

Next Post

Spinal Muscular Atrophy Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Novartis, Hoffmann-La Roche, Genentech, Inc., Scholar Rock, Roche, Cytokinetics, Biogen

Next Post

Spinal Muscular Atrophy Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Novartis, Hoffmann-La Roche, Genentech, Inc., Scholar Rock, Roche, Cytokinetics, Biogen

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.